Insulin-like growth factor I effect on the number of osteoblast progenitors is impaired in ovariectomized mice

Journal of Bone and Mineral Research

Volumn 17, Issue 9, 2002, Pages 1579-1587

  Kasukawa, Yuji ^a   Stabnov, Lisa ^a   Miyakoshi, Naohisa ^a   Baylink, David J ^a,b   Mohan, Subburaman ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone formation; Insulin like growth factor I; Mice; Osteoblast progenitors; Ovariectomy

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; ALKALINE PHOSPHATASE; GONADORELIN RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MATRIX; CELL DIFFERENTIATION; COLLAGEN METABOLISM; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HORMONAL REGULATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OVARIECTOMY; STEM CELL; ANIMAL; BIOLOGICAL MODEL; C3H MOUSE; C57BL MOUSE; CLONOGENIC ASSAY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; IN VITRO STUDY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ALKALINE PHOSPHATASE; ANIMALS; COLONY-FORMING UNITS ASSAY; FEMALE; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; OSTEOBLASTS; OVARIECTOMY; RECEPTORS, LHRH; RECOMBINANT PROTEINS; STEM CELLS;

EID: 0036708146     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.9.1579     Document Type: Article

References (57)

1. Osteoblast biology
2. Molecular mechanisms mediating developmental and hormone regulated expression of genes in osteoblasts: An integrated relationship of cell growth and differentiation
3. Osteoblastic cell lineage
4. Bone cell biology: The regulation of development, structure, and function in the skeleton
5. Osteoblastic differentiation
6. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells
7. Stromal colonies from mouse marrow: Characterization of cell types, optimization of plating efficiency and its effect on radiosensitivity
8. Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F
9. Growth factors to stimulate bone formation
10. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures
11. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women
12. The skeletal structure of insulin-like growth factor I-deficient mice
13. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: Relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures
14. Age-related changes in insulin-like growth factor II and II in human femoral cortical bone: Lack of correlation with bone mass
15. Mitogenic activity but not phenotype expression of rat osteoprogenitor cells in response to IGF-I is impaired in aged rats
16. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor
17. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormonestimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones
18. Mechanical strain stimulates ROS cell proliferation through IGF-II and estrogen through IGF-I
19. Estrogeninduced factors of breast cancer cells partially replace estrogen to promote tumor growth
20. Estrogen regulation of the estrogen receptor and insulin-like growth factor-I in the rat uterus: A potential coupling between effects of estrogen and IGF-I
21. Growth factors interact with estradiol and gonadotropins in the regulation of ovarian cancer cell growth and growth factor receptors
22. Estradiol modulates insulin-like growth factor I receptors and binding proteins in neurons from the hypothalamus
23. Estrogen receptors and insulin-like growth factor-1 receptors mediate estrogen-dependent synaptic plasticity
24. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
25. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function
26. Age-related changes in osteogenic stem cells in mice
27. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium
28. Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids
29. Development and application of a synthetic peptide based osteocalcin assay for the measurement of bone formation in mouse serum
30. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone
31. Response of bipotential human marrow stromal cells to insulin-like growth factors: Effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes
32. Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone
33. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow
34. Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss
35. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels
36. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates
37. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats
38. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption
39. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3
40. Effects of progesterone on serum levels of IGF-I and on femur IGF-I mRNA in ovariectomized rats
41. An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats
42. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol
43. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics
44. Benefit of systemically administrated rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats
45. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17β-estradiol, on bone and mineral homeostasis of aged ovariectomized rats
46. Stimulation of trabecular bone formation by insulin-like growth factor I in adult ovariectomized rats
47. Effects of IGF-I, alone and in combination with 17β-oestradiol, on bone remodelling parameters in ovariectomized rats
48. The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components
49. Differential cross-talk of estrogen and growth factor receptors in two human mammary tumor cell lines
50. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
51. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow
52. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
53. 3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow
54. Recombinant TGF-beta 1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice
55. Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro
56. Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow
57. Effects of high-dose estrogen on murine hematopoietic bone marrow precede those on osteogenesis